M. Agbandje-mckenna and J. Kleinschmidt, AAV capsid structure and cell interactions, Methods Mol Biol, vol.807, pp.47-92, 2011.

A. Asokan, J. C. Conway, J. L. Phillips, C. Li, J. Hegge et al., Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle, Nat Biotechnol, vol.28, pp.79-82, 2010.

I. Audo, S. Kohl, B. P. Leroy, F. L. Munier, X. Guillonneau et al., TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness, Am J Hum Genet, vol.85, pp.720-729, 2009.

J. Bainbridge, A. J. Smith, S. S. Barker, R. S. Henderson, R. Balaggan et al., Effect of gene therapy on visual function in Leber's congenital amaurosis, N Engl J Med, vol.358, pp.2231-2239, 2008.

M. Bartel, D. Schaffer, and H. Büning, Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity, Front Microbiol, vol.2, p.204, 2011.

A. Bi, J. Cui, Y. Ma, E. Olshevskaya, M. Pu et al., Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration, Neuron, vol.50, pp.23-33, 2006.

V. Busskamp, J. Duebel, D. Balya, M. Fradot, T. J. Viney et al., Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa, Science, vol.329, pp.413-417, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00496717

A. V. Cideciyan, W. W. Hauswirth, T. S. Aleman, S. Kaushal, S. B. Schwartz et al., Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year, Hum Gene Ther, vol.20, pp.999-1004, 2009.

D. Dalkara, L. C. Byrne, R. R. Klimczak, M. Visel, L. Yin et al., In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous, Sci Transl Med, vol.5, pp.189-76, 2013.

A. Dhingra, P. Sulaiman, Y. Xu, M. E. Fina, R. W. Veh et al., Probing neurochemical structure and function of retinal ON bipolar cells with a transgenic mouse, J Comp Neurol, vol.510, pp.484-496, 2008.

M. M. Doroudchi, K. P. Greenberg, J. Liu, K. A. Silka, E. S. Boyden et al., Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness, Mol Ther, vol.19, pp.1220-1229, 2011.

M. Fradot, V. Busskamp, V. Forster, T. Cronin, T. Léveillard et al., Gene therapy in ophthalmology: validation on cultured retinal cells and explants from postmortem human eyes, Hum Gene Ther, vol.22, pp.587-593, 2011.

A. Girod, M. Ried, C. Wobus, H. Lahm, K. Leike et al., Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2, Nat Med, vol.5, p.1438, 1999.
URL : https://hal.archives-ouvertes.fr/hal-00314853

J. C. Grieger, V. W. Choi, and R. J. Samulski, Production and characterization of adeno-associated viral vectors, Nat Protoc, vol.1, pp.1412-1428, 2006.

B. L. Gurda, C. Raupp, R. Popa-wagner, M. Naumer, N. H. Olson et al., Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8, 2012.

, J Virol, vol.86, pp.7739-7751

M. C. Hanna and D. J. Calkins, Expression of genes encoding glutamate receptors and transporters in rod and cone bipolar cells of the primate retina determined by single-cell polymerase chain reaction, Mol Vis, vol.13, pp.2194-2208, 2007.

W. W. Hauswirth, T. S. Aleman, S. Kaushal, A. V. Cideciyan, S. B. Schwartz et al., Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial, Hum Gene Ther, vol.19, pp.979-990, 2008.

C. J. Jeon, E. Strettoi, and R. H. Masland, The major cell populations of the mouse retina, J Neurosci, vol.18, pp.8936-8946, 1998.

B. W. Jones, C. B. Watt, J. M. Frederick, W. Baehr, C. Chen et al., Retinal remodeling triggered by photoreceptor degenerations, J Comp Neurol, vol.464, pp.1-16, 2003.

A. Kern, K. Schmidt, C. Leder, O. J. Müller, C. E. Wobus et al., Identification of a heparin-binding motif on adeno-associated virus type 2 capsids, J Virol, vol.77, pp.11072-11081, 2003.

E. Kienle, E. Senís, K. Börner, D. Niopek, E. Wiedtke et al., Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling, J Vis Exp, 2012.

D. S. Kim, T. Matsuda, and C. L. Cepko, A core paired-type and POU homeodomain-containing transcription factor program drives retinal bipolar cell gene expression, J Neurosci, vol.28, pp.7748-7764, 2008.

S. Kleinlogel, K. Feldbauer, R. E. Dempski, H. Fotis, P. G. Wood et al., Ultra light-sensitive and fast neuronal activation with the Ca 2+ -permeable channelrhodopsin CatCh, Nat Neurosci, vol.14, pp.513-518, 2011.

P. S. Lagali, D. Balya, G. B. Awatramani, T. A. Münch, D. S. Kim et al., Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration, Nat Neurosci, vol.11, pp.667-675, 2008.

M. A. Lochrie, G. P. Tatsuno, B. Christie, J. W. Mcdonnell, S. Zhou et al., Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization, J Virol, vol.80, pp.821-834, 2006.

A. M. Maguire, F. Simonelli, E. A. Pierce, E. N. Pugh, F. Mingozzi et al., Safety and efficacy of gene transfer for Leber's congenital amaurosis, N Engl J Med, vol.358, pp.2240-2248, 2008.

N. Maheshri, J. T. Koerber, B. K. Kaspar, and D. V. Schaffer, Directed evolution of adeno-associated virus yields enhanced gene delivery vectors, Nat Biotechnol, vol.24, pp.198-204, 2006.

R. H. Masland, The neuronal organization of the retina, Neuron, vol.76, pp.266-280, 2012.

M. Masu, H. Iwakabe, Y. Tagawa, T. Miyoshi, M. Yamashita et al., Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene, Cell, vol.80, pp.757-765, 1995.

S. Michelfelder, K. Varadi, C. Raupp, A. Hunger, J. Körbelin et al., Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo, PLoS ONE, vol.6, p.23101, 2011.

A. M. Mitchell, S. C. Nicolson, J. K. Warischalk, and R. J. Samulski, AAV's anatomy: roadmap for optimizing vectors for translational success, Curr Gene Ther, vol.10, pp.319-340, 2010.

C. W. Morgans, J. Zhang, B. G. Jeffrey, S. M. Nelson, N. S. Burke et al., TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells, Proc Natl Acad Sci, vol.106, pp.19174-19178, 2009.

N. Muranaka, T. Hohsaka, and M. Sisido, Four-base codon mediated mRNA display to construct peptide libraries that contain multiple nonnatural amino acids, Nucleic Acids Res, vol.34, p.7, 2006.

N. Muzyczka and K. H. Warrington, Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism, Hum Gene Ther, vol.16, pp.408-416, 2005.

G. Nagel, T. Szellas, W. Huhn, S. Kateriya, N. Adeishvili et al., Channelrhodopsin-2, a directly light-gated cation-selective membrane channel, Proc Natl Acad Sci, vol.100, pp.13940-13945, 2003.

H. Nam, M. D. Lane, E. Padron, B. Gurda, R. Mckenna et al., Structure of adeno-associated virus serotype 8, a gene therapy vector, J Virol, vol.81, pp.12260-12271, 2007.

A. Nomura, R. Shigemoto, Y. Nakamura, N. Okamoto, N. Mizuno et al., Developmentally regulated postsynaptic localization of a metabotropic glutamate receptor in rat rod bipolar cells, Cell, vol.77, pp.361-369, 1994.

S. R. Opie, K. H. Warrington, M. Agbandje-mckenna, S. Zolotukhin, and N. Muzyczka, Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding, J Virol, vol.77, pp.6995-7006, 2003.

E. Padron, V. Bowman, N. Kaludov, L. Govindasamy, H. Levy et al., Structure of adeno-associated virus type 4, J Virol, vol.79, pp.5047-5058, 2005.

N. S. Peachey, J. N. Pearring, P. Bojang, M. E. Hirschtritt, G. Sturgill-short et al., Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation, J Neurophysiol, vol.108, pp.2442-2451, 2012.

L. Perabo, D. Goldnau, K. White, J. Endell, J. Boucas et al., Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism, J Virol, vol.80, pp.7265-7269, 2006.

M. W. Pfaffl, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res, vol.29, p.45, 2001.

T. A. Ray, K. M. Heath, N. Hasan, J. M. Noel, I. S. Samuels et al., GPR179 is required for high sensitivity of the mGluR6 signaling cascade in depolarizing bipolar cells, J Neurosci, vol.34, pp.6334-6343, 2014.

R. A. Shiells and G. Falk, Responses of rod bipolar cells isolated from dogfish retinal slices to concentration-jumps of glutamate, Vis Neurosci, vol.11, pp.1175-1183, 1994.

S. Siegert, E. Cabuy, B. G. Scherf, H. Kohler, S. Panda et al., Transcriptional code and disease map for adult retinal cell types, Nat Neurosci, vol.15, pp.1-2, 2012.

S. Siegert, B. G. Scherf, D. Punta, K. Didkovsky, N. Heintz et al., Genetic address book for retinal cell types, Nat Neurosci, vol.12, pp.1197-1204, 2009.

F. Simonelli, A. M. Maguire, F. Testa, E. A. Pierce, F. Mingozzi et al., Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration, Mol Ther, vol.18, pp.643-650, 2010.

K. Stieger, T. Cronin, J. Bennett, and F. Rolling, Adeno-associated virus mediated gene therapy for retinal degenerative diseases, Methods Mol Biol, vol.807, pp.179-218, 2011.

Y. Ueda, H. Iwakabe, M. Masu, M. Suzuki, and S. Nakanishi, The mGluR6 5 0 upstream transgene sequence directs a cell-specific and developmentally regulated expression in retinal rod and ON-type cone bipolar cells, J Neurosci, vol.17, pp.3014-3023, 1997.

L. H. Vandenberghe, P. Bell, A. M. Maguire, C. N. Cearley, R. Xiao et al., Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey, Sci Transl Med, vol.3, pp.88-54, 2011.

N. Vardi and K. Morigiwa, ON cone bipolar cells in rat express the metabotropic receptor mGluR6, Vis Neurosci, vol.14, pp.789-794, 1997.

S. Williams and K. Deisseroth, Optogenetics. Proc Natl Acad Sci, vol.110, p.16287, 2013.

C. E. Wobus, B. Hugle-dorr, A. Girod, G. Petersen, M. Hallek et al., Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection, J Virol, vol.74, pp.9281-9293, 2000.

Z. Wu, A. Asokan, J. C. Grieger, L. Govindasamy, M. Agbandje-mckenna et al., Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes, J Virol, vol.80, pp.11393-11397, 2006.

Q. Xie, W. Bu, S. Bhatia, J. Hare, T. Somasundaram et al., The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy, Proc Natl Acad Sci, vol.99, pp.10405-10410, 2002.

L. Yang, J. Li, and X. Xiao, Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy, Methods Mol Biol, vol.709, pp.127-139, 2011.

C. Zeitz, M. Van-genderen, J. Neidhardt, U. Luhmann, F. Hoeben et al., Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram, Invest Ophthalmol Vis Sci, vol.46, pp.4328-4335, 2005.

, License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited